§ 54.1-3446

Schedule I

The controlled substances listed in this section are included in Schedule I:

1. Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation:

Acetylmethadol;Allylprodine;Alphacetylmethadol (except levo-alphacetylmethadol, also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM);Alphameprodine;Alphamethadol;Benzethidine;Betacetylmethadol;Betameprodine;Betamethadol;Betaprodine;Clonitazene;Dextromoramide;Diampromide;Diethylthiambutene;Difenoxin;Dimenoxadol;Dimepheptanol;Dimethylthiambutene;Dioxaphetylbutyrate;Dipipanone;Ethylmethylthiambutene;Etonitazene;Etoxeridine;Furethidine;Hydroxypethidine;Ketobemidone;Levomoramide;Levophenacylmorphan;Morpheridine;Noracymethadol;Norlevorphanol;Normethadone;Norpipanone;Phenadoxone;Phenampromide;Phenomorphan;Phenoperidine;Piritramide;Proheptazine;Properidine;Propiram;Racemoramide;Tilidine;Trimeperidine.

2. Any of the following opium derivatives, their salts, isomers and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers and salts of isomers is possible within the specific chemical designation:

Acetorphine;Acetyldihydrocodeine;Benzylmorphine;Codeine methylbromide;Codeine-N-Oxide;Cyprenorphine;Desomorphine;Dihydromorphine;Drotebanol;Etorphine;Heroin;Hydromorphinol;Methyldesorphine;Methyldihydromorphine;Morphine methylbromide;Morphine methylsulfonate;Morphine-N-Oxide;Myrophine;Nicocodeine;Nicomorphine;Normorphine;Pholcodine;Thebacon.

3. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation, which contains any quantity of the following hallucinogenic substances, or which contains any of its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation (for purposes of this subdivision only, the term “isomer” includes the optical, position, and geometric isomers):

Alpha-ethyltryptamine (some trade or other names: Monase;a-ethyl-1H-indole-3-ethanamine; 3-2-aminobutyl] indole; a-ET; AET);4-Bromo-2,5-dimethoxyphenethylamine (some trade or other names: 2-4-bromo-2,5-dimethoxyphenyl]-1-aminoethane;alpha-desmethyl DOB; 2C-B; Nexus);4-Bromo-2,5-dimethoxyphenethylamine (some trade or other names: 2-4-bromo-2,5-dimethoxyphenyl]-1-aminoethane;alpha-desmethyl DOB; 2C-B; Nexus);3,4-methylenedioxy amphetamine;5-methoxy-3,4-methylenedioxy amphetamine;3,4,5-trimethoxy amphetamine;Alpha-methyltryptamine (other name: AMT);Bufotenine;Diethyltryptamine;Dimethyltryptamine;4-methyl-2,5-dimethoxyamphetamine;2,5-dimethoxy-4-ethylamphetamine (DOET);2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7);Ibogaine;5-methoxy-N,N-diisopropyltryptamine (other name: 5-MeO-DIPT);Lysergic acid diethylamide;Mescaline;Parahexyl (some trade or other names: 3-Hexyl-1-hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo -b,d] pyran; Synhexyl);Peyote;N-ethyl-3-piperidyl benzilate;N-methyl-3-piperidyl benzilate;Psilocybin;Psilocyn;Salvinorin A;Tetrahydrocannabinols, except as present in marijuana and dronabinol in sesame oil and encapsulated in a soft gelatin capsule in a drug product approved by the U.S. Food and Drug Administration;Hashish oil (some trade or other names: hash oil; liquid marijuana; liquid hashish);2,5-dimethoxyamphetamine (some trade or other names: 2,5-dimethoxy-a-methylphenethylamine; 2,5-DMA);3,4-methylenedioxymethamphetamine (MDMA), its optical, positional and geometric isomers, salts and salts of isomers;3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha-methyl-3,4 (methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA);N-hydroxy-3,4-methylenedioxyamphetamine (some other names: N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA);4-bromo-2,5-dimethoxyamphetamine (some trade or other names: 4-bromo-2,5-dimethoxy-a-methylphenethylamine; 4-bromo-2,5-DMA);4-methoxyamphetamine (some trade or other names: 4-methoxy-a-methylphenethylamine; paramethoxyamphetamine; PMA);Ethylamine analog of phencyclidine (some other names: N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE);Pyrrolidine analog of phencyclidine (some other names: 1-(1-phenylcyclohexyl) -pyrrolidine, PCPy, PHP);Thiophene analog of phencyclidine (some other names: 1-1-(2-thienyl) -cyclohexyl]-piperidine, 2-thienyl analog of phencyclidine, TPCP, TCP);1-1-(2-thienyl)cyclohexyl]pyrrolidine (other name: TCPy);3,4-methylenedioxypyrovalerone (other name: MDPV);4-methylmethcathinone (other names: mephedrone, 4-MMC);3,4-methylenedioxymethcathinone (other name: methylone);Naphthylpyrovalerone (other name: naphyrone);4-fluoromethcathinone (other name: flephedrone, 4-FMC);4-methoxymethcathinone (other names: methedrone; bk-PMMA);Ethcathinone (other name: N-ethylcathinone);3,4-methylenedioxyethcathinone (other name: ethylone);Beta-keto-N-methyl-3,4-benzodioxyolybutanamine (other name: butylone);N,N-dimethylcathinone (other name: metamfepramone);Alpha-pyrrolidinopropiophenone (other name: alpha-PPP);4-methoxy-alpha-pyrrolidinopropiophenone (other name: MOPPP);3,4-methylenedioxy-alpha-pyrrolidinopropiophenone (other name: MDPPP);Alpha-pyrrolidinovalerophenone (other name: alpha-PVP);6,7-dihydro-5H-indeno-(5,6-d)-1,3-dioxol-6-amine (other name: MDAI);3-fluoromethcathinone (other name: 3-FMC);4-Ethyl-2,5-dimethoxyphenethylamine (other name: 2C-E);4-Iodo-2,5-dimethoxyphenethylamine (other name: 2C-I);4-Methylethcathinone (other name: 4-MEC);4-Ethylmethcathinone (other name: 4-EMC);N,N-diallyl-5-methoxytryptamine (other name: 5-MeO-DALT);Beta-keto-methylbenzodioxolylpentanamine (other name: Pentylone, bk-MBDP);Alpha-methylamino-butyrophenone (other name: Buphedrone);Alpha-methylamino-valerophenone (other name: Pentedrone);3,4-Dimethylmethcathinone (other name: 3.4-DMMC);4-methyl-alpha-pyrrolidinopropiophenone (other name: MPPP);4-Iodo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (other names: 25-I, 25I-NBOMe);Methoxetamine (other names: MXE, 3-MeO-2-Oxo-PCE);4-Fluoromethamphetamine (other name: 4-FMA);4-Fluoroamphetamine (other name: 4-FA);2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (other name: 2C-D);2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (other name: 2C-C);2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (other name: 2C-T-2);2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (other name: 2C-T-4);2-(2,5-Dimethoxyphenyl)ethanamine (other name: 2C-H);2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (other name: 2C-N);2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (other name: 2C-P);(2-aminopropyl)benzofuran (other name: APB);(2-aminopropyl)-2,3-dihydrobenzofuran (other name: APDB);4-chloro-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (other names: 2C-C-NBOMe, 25C-NBOMe);4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (other names: 2C-B-NBOMe, 25B-NBOMe);Acetoxydimethyltryptamine (other names: AcO-Psilocin, AcO-DMT, Psilacetin);Benocyclidine (other names: BCP, BTCP);Alpha-pyrrolidinobutiophenone (other name: alpha-PBP);3,4-methylenedioxy-N,N-dimethylcathinone (other names: Dimethylone, bk-MDDMA);4-bromomethcathinone (other name: 4-BMC);4-chloromethcathinone (other name: 4-CMC);4-Iodo-2,5-dimethoxy-N-[(2-hydroxyphenyl)methyl]-benzeneethanamine (other name: 25I-NBOH);lpha-Pyrrolidinohexiophenone (other name: alpha-PHP);Alpha-Pyrrolidinoheptiophenone (other name: PV8).

4. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers and salts of isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:

Gamma hydroxybutyric acid (some other names include GHB; gamma hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate);Mecloqualone;Methaqualone.Etizolam.

5. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers and salts of isomers:

Aminorex (some trade or other names; aminoxaphen; 2-amino-5-phenyl-2-oxazoline; 4, 5-dihydro-5-phenyl-2-oxazolamine);N-Benzylpiperazine (some other names: BZP, 1-benzylpiperazine);Fenethylline;Ethylamphetamine;Cathinone (some trade or other names: 2-amino-1-phenyl-1-propanone, alpha-aminopropiophenone, 2-aminopropiophenone, norephedrone), and any plant material from which Cathinone may be derived;Methcathinone (some other names: 2-(methylamino)-propiophenone; alpha-(methylamino)-propiophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR 1432);Cis-4-methylaminorex (other name: cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);N,N-dimethylamphetamine (other names: N,N-alpha-trimethyl-benzeneethanamine, N,N-alpha-trimethylphenethylamine).

6. Any material, compound, mixture or preparation containing any quantity of the following substances:

N-3-methyl-1-(2-phenethyl)-4-piperidyl]-N-phenylpropanamide (other name: 3-methylfentanyl), its optical and geometric isomers, salts, and salts of isomers;1-methyl-4-phenyl-4-propionoxypiperidine (other name: MPPP), its optical isomers, salts and salts of isomers;1-(2-phenylethyl)-4-phenyl-4-acetyloxypiperidine (other name: PEPAP), its optical isomers, salts and salts of isomers;N-1-(alpha-methyl-beta-phenyl) ethyl-4-piperidyl] propionanilide (other names: 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine), alpha-methylfentanyl);N-1-(1-methyl-2-phenethyl)-4-piperidyl]-N-phenylacetamide (other name: acetyl-alpha-methylfentanyl), its optical isomers, salts and salts of isomers;N-1-(1-methyl-2-2-thienyl)ethyl-4 piperidyl]-N-phenylpropanamide (other name: alpha-methylthiofentanyl), its optical isomers, salts and salts of isomers;N-1-benzyl-4-piperidyl]N-phenylpropanamide (other name: benzylfentanyl), its optical isomers, salts and salts of isomers;N-1-(2-hydroxy-2-phenyl) ethyl-4-piperidyl]-N-phenylpropanamide (other name: beta-hydroxyfentanyl), its optical isomers, salts and salts of isomers;N-3-methyl-1-(2-hydroxy-2-phenethyl)4-piperidyl]-N-phenylpropanamide (other name: beta-hydroxy-3-methylfentanyl), its optical and geometric isomers, salts and salts of isomers;N-(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide (other name: 3-methylthiofentanyl), its optical and geometric isomers, salts and salts of isomers;N-1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (other name: thienylfentanyl), its optical isomers, salts and salts of isomers;N-phenyl-N-1-(2-thienyl)ethyl-4-piperidinyl]-propanamide (other name: thiofentanyl), its optical isomers, salts and salts of isomers;N-(4-fluorophenyl)-N-1-(2-phenethyl)-4-piperidinyl]-propanamide (other name: para-fluorofentanyl), its optical isomers, salts and salts of isomers;Acetyl fentanyl (other name: desmethyl fentanyl).

7. Any substance that contains one or more cannabimimetic agents or that contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation, and any preparation, mixture, or substance containing, or mixed or infused with, any detectable amount of one or more cannabimimetic agents.

a. “Cannabimimetic agents” includes any substance that is within any of the following structural classes:

2-(3-hydroxycyclohexyl)phenol with substitution at the 5-position of the phenolic ring by alkyl or alkenyl, whether or not substituted on the cyclohexyl ring to any extent;3-(1-naphthoyl)indole or 1H-indol-3-yl-(1-naphthyl)methane with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the naphthoyl or naphthyl ring to any extent;3-(1-naphthoyl)pyrrole with substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted in the pyrrole ring to any extent, whether or not substituted on the naphthoyl ring to any extent;1-(1-naphthylmethyl)indene with substitution of the 3-position of the indene ring, whether or not further substituted in the indene ring to any extent, whether or not substituted on the naphthyl ring to any extent;3-phenylacetylindole or 3-benzoylindole with substitution at the nitrogen atom of the indole ring, whether or not further substituted in the indole ring to any extent, whether or not substituted on the phenyl ring to any extent;3-cyclopropoylindole with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the cyclopropyl ring to any extent;3-adamantoylindole with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the adamantyl ring to any extent;N-(adamantyl)-indole-3-carboxamide with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent, whether or not substituted on the adamantyl ring to any extent; andN-(adamantyl)-indazole-3-carboxamide with substitution at a nitrogen atom of the indazole ring, whether or not further substituted on the indazole ring to any extent, whether or not substituted on the adamantyl ring to any extent.

b. The term “cannabimimetic agents” includes:

5-(1,1-Dimethylheptyl)-2-[3-hydroxycyclohexyl]-phenol (other name: CP 47,497);5-(1,1-Dimethylhexyl)-2-[3-hydroxycyclohexyl]-phenol (other name: CP 47,497 C6 homolog);5-(1,1-Dimethyloctyl)-2-[3-hydroxycyclohexyl]-phenol (other name: CP 47,497 C8 homolog);5-(1,1-Dimethylnonyl)-2-[3-hydroxycyclohexyl]-phenol (other name: CP 47,497 C9 homolog);1-pentyl-3-(1-naphthoyl)indole (other names: JWH-018, AM-678);1-butyl-3-(1-naphthoyl)indole (other name: JWH-073);1-pentyl-3-(2-methoxyphenylacetyl)indole (other name: JWH-250);1-hexyl-3-(naphthalen-1-oyl)indole (other name: JWH-019);1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (other name: JWH-200);(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-te trahydrobenzo[c]chromen-1-ol (other name: HU-210);1-pentyl-3-(4-methoxy-1-naphthoyl)indole (other name: JWH-081);1-pentyl-3-(4-methyl-1-naphthoyl)indole (other name: JWH-122);1-pentyl-3-(2-chlorophenylacetyl)indole (other name: JWH-203);1-pentyl-3-(4-ethyl-1-naphthoyl)indole (other name: JWH-210);1-pentyl-3-(4-chloro-1-naphthoyl)indole (other name: JWH-398);1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (other name: AM-694);1-((N-methylpiperidin-2-yl)methyl)-3-(1-naphthoyl)indole (other name: AM-1220);1-(5-fluoropentyl)-3-(1-naphthoyl)indole (other name: AM-2201);1-[(N-methylpiperidin-2-yl)methyl]-3-(2-iodobenzoyl)indole (other name: AM-2233);Pravadoline (4-methoxyphenyl)-[2-methyl-1-(2-(4-morpholinyl)ethyl)indol-3-yl]methanone (other name: WIN 48,098);1-pentyl-3-(4-methoxybenzoyl)indole (other names: RCS-4, SR-19);1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole (other names: RCS-8, SR-18);1-pentyl-3-(2,2,3,3-tetramethylcyclopropylmethanone)indole (other name: UR-144);1-(5-fluoropentyl)-3-(2,2,3,3-tetramethylcyclopropylmethanone)indole (other name: XLR-11);N-adamantyl-1-fluoropentylindole-3-carboxamide (other name: STS-135);N-adamantyl-1-pentylindazole-3-carboxamide (other name: AKB48);1-pentyl-3-(1-adamantoyl)indole (other name: AB-001);(8-quinolinyl)(1-pentylindol-3-yl)carboxylate (other name: PB-22);(8-quinolinyl)(1-(5-fluoropentyl)indol-3-yl)carboxylate (other name: 5-fluoro-PB-22);(8-quinolinyl)(1-cyclohexylmethyl-indol-3-yl)carboxylate (other name: BB-22);N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentylindazole-3-carboxamide (other name: AB-PINACA);N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)indazole-3-carboxamide (other name: AB-FUBINACA);1-(5-fluoropentyl)-3-(1-naphthoyl)indazole (other name: THJ-2201);N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentylindazole-3-carboxamide (other name: ADB-PINACA);N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide (other name: AB-CHMINACA);N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)indazole-3-carboxamide (other name: 5-fluoro-AB-PINACA);N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide (other names: ADB-CHMINACA, MAB-CHMINACA);Methyl-2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (other name: 5-fluoro-AMB);1-naphthalenyl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (other name: NM-2201);1-(4-fluorobenzyl)-3-(2,2,3,3-tetramethylcyclopropylmethanone)indole (other name: FUB-144);1-(5-fluoropentyl)-3-(4-methyl-1-naphthoyl)indole (other name MAM-2201).

History

1972, c. 798, § 54-524.84:4; 1973, c. 479; 1976, c. 614; 1977, c. 302; 1979, cc. 387, 435; 1982, c. 505; 1984, cc. 186, 192; 1986, c. 463; 1988, c. 765; 1994, c. 763; 1996, c. 408; 1997, c. 594; 1999, c. 722; 2000, c. 348; 2005, c. 119; 2008, c. 59; 2011, cc. 384, 410; 2012, cc. 762, 816; 2013, cc. 295, 785; 2014, cc. 674, 719; 2015, cc. 726, 757; 2016, cc. 103, 112.

Download

  • Plain Text
  • JSON
  • XML

Comments